MKI67 and breast carcinoma: This is supported by the substantial correlation that exists between protein and mRNA expression in general [15] and for breast cancer biomarkers in particular [16–18] and by the desire to increase the reproducibility of biomarker testing, in particular for the assessment of proliferative activity (i.e.Ki-67) [19].